Lv4
658 积分 2025-06-24 加入
Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data
26分钟前
待确认
Multiparatopic antibodies overcome tyrosine kinase inhibitor resistance by inducing lysosomal degradation of EGFR mutants
13小时前
已完结
Modular assembly and evaluation of a TROP2-targeting immunotoxin for cancer therapy
1个月前
已完结
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
2个月前
已完结
Moxetumomab pasudotox for hairy cell leukemia: preclinical development to FDA approval
2个月前
已完结
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan
2个月前
已完结
Evolution of TROP2: Biological insights and clinical applications
2个月前
已完结
ILD with Datopotamab Deruxtecan combinations: A warning signal we should not ignore
2个月前
已关闭
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
2个月前
已完结
Upregulation of Trop-2 quantitatively stimulates human cancer growth
2个月前
已完结
皖公网安备34019202002308
